Biostage (Nasdaq: $BSTG) is developing bioengineered organ implants using its Cellframe™ technology, including the patient's stem cells, to treat life-threatening conditions of the esophagus, bronchus or trachea.
Equities Trader at Grace Trading, Chartered Market Technician, Yahoo Finance contributor. University of Kentucky graduate. No statements should be construed as investment advice. Follow on Twitter: @wildcattrader